 Resverlogix Provides Update on BETonMACE Phase 3 Epigenetics Trial PM360Resverlogix Provides Update on BETonMACE ...BOSTON, Oct. 24, 2017 GLOBE NEWSWIRE -- Paratek Pharmaceuticals, Inc. Nasdaq:PRTK, a biopharmaceutical company ... 